Clincosm LogoSign in Get a demo

Endometrial Adenocarcinoma

Showing 1 - 25 of 36
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Cancer, Endometrial Adenocarcinoma Trial (Cadonilimab, Carboplatin, Cisplatin)

Not yet recruiting
  • Endometrial Cancer
  • Endometrial Adenocarcinoma
  • (no location specified)
Oct 7, 2023

Endometrial Cancer, Endometrial Adenocarcinoma Trial in Guangzhou (Cadonilimab, Lenvatinib)

Not yet recruiting
  • Endometrial Cancer
  • Endometrial Adenocarcinoma
  • Guangzhou, China
    Sun Yat-sen University Cancer Cetntre
Apr 9, 2023

Platinum-resistant Ovarian Cancer, Endometrial Adenocarcinoma, Urothelial Carcinoma Trial in Canton (ACR-368, Gemcitabine,

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +2 more
  • Mobile, Alabama
  • +7 more
Jan 24, 2023

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States

Active, not recruiting
Has Results
  • Endometrial Adenocarcinoma
  • +9 more
  • Bevacizumab
  • +5 more
  • Phoenix, Arizona
  • +232 more
Jan 12, 2023

Endometrial Adenocarcinoma Trial in Helsinki (Comparison of adjuvant therapies)

Recruiting
  • Endometrial Adenocarcinoma
  • Comparison of adjuvant therapies
  • Helsinki, Finland
    Helsinki University Hospital
Dec 8, 2022

Endometrial Adenocarcinoma, Endometrial Carcinoma, Lynch Syndrome Trial in United States (Genetic Counseling, Genetic Testing,

Active, not recruiting
  • Endometrial Adenocarcinoma
  • +3 more
  • Genetic Counseling
  • +3 more
  • Akron, Ohio
  • +8 more
Dec 2, 2022

Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Endometrial Adenocarcinoma Trial in Houston (Copanlisib,

Recruiting
  • Deleterious BRCA1 Gene Mutation
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 23, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma Trial (AMT-151)

Not yet recruiting
  • Advanced Solid Tumor
  • +18 more
  • (no location specified)
Aug 10, 2022

PTEN Expression in Functional and Pathological Endometrial

Completed
  • Endometrial Hyperplasia
  • Endometrial Adenocarcinoma
  • routine stain by H&E.
  • Sohag, Egypt
    Maisa Hashem Mohammed
Jul 13, 2022

Endometrial Cancer, Endometrial Adenocarcinoma Trial in United States (Pembrolizumab, Paclitaxel, Carboplatin)

Completed
Has Results
  • Endometrial Cancer
  • Endometrial Adenocarcinoma
  • Mesa, Arizona
  • +5 more
Feb 17, 2022

Carcinoma, Endometrial Adenocarcinoma, Tumors Trial in United States (PEN-866 Sodium, fluorouracil, Folinic acid)

Recruiting
  • Carcinoma
  • +18 more
  • PEN-866 Sodium
  • +3 more
  • Springdale, Arkansas
  • +15 more
Feb 16, 2022

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States

Completed
Has Results
  • Endometrial Adenocarcinoma
  • +4 more
  • Akt Inhibitor MK2206
  • Laboratory Biomarker Analysis
  • Boston, Massachusetts
  • +6 more
Jan 13, 2022

Endometrial Adenocarcinoma, Endometrial Carcinosarcoma Trial in United States (Nivolumab, BMS- 986205)

Active, not recruiting
  • Endometrial Adenocarcinoma
  • Endometrial Carcinosarcoma
  • Basking Ridge, New Jersey
  • +6 more
Nov 29, 2021

Endometrial Cancer, Endometrial Tumors, Endometrial Adenocarcinoma Trial in Istra (Laparoscopic hysterectomy with sentinel lymph

Recruiting
  • Endometrial Cancer
  • +8 more
  • Laparoscopic hysterectomy with sentinel lymph node biopsy
  • Istra, Moscow Region, Russian Federation
    Department of Gynecologic Oncology, Moscow City Oncology Hospita
Oct 8, 2021

Endometrial Atypical Hyperplasia, Endometrial Adenocarcinoma Trial in Shanghai, Hangzhou (Megestrol acetate and metformin,

Completed
Has Results
  • Endometrial Atypical Hyperplasia
  • Endometrial Adenocarcinoma
  • Megestrol acetate and metformin
  • Megestrol acetate
  • Shanghai, Shanghai, China
  • +4 more
Sep 10, 2021

Endometrial Adenocarcinoma, Stage IA Uterine Corpus Cancer, Stage IB Uterine Corpus Cancer Trial in Bronx (drug, radiation,

Terminated
  • Endometrial Adenocarcinoma
  • +8 more
  • Bronx, New York
    Albert Einstein College of Medicine
Apr 21, 2021

Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma Trial in United States

Completed
  • Endometrial Adenocarcinoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Hartford, Connecticut
  • +21 more
Oct 13, 2020

Sentinel Lymph Node Policy in High-risk Endometrial Carcinoma

Completed
  • Endometrial Adenocarcinoma
  • SLN mapping
  • Shanghai, China
    Obstetrics and Gynecology Hospital, Fudan University
Jun 21, 2020

Endometrial Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Canada, United

Completed
Has Results
  • Endometrial Adenocarcinoma
  • +7 more
  • Sunitinib Malate
  • Beverly Hills, California
  • +28 more
Feb 14, 2020

Endometrial Adenocarcinoma Trial in Assuit (Ketamine, dexmedetomidine, bupivacaine)

Completed
  • Endometrial Adenocarcinoma
  • Assuit, Egypt
    South Egypt Cancer instIitute
Jan 19, 2020

Endometrial Adenocarcinoma, ERBB2 Gene Amplification, Recurrent Uterine Corpus Carcinoma Trial in Philadelphia (Laboratory

Completed
  • Endometrial Adenocarcinoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Trastuzumab
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 30, 2019

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States

Completed
Has Results
  • Endometrial Adenocarcinoma
  • +3 more
  • Los Angeles, California
  • +71 more
Jul 19, 2019

Endometrial Cancer, Endometrial Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Oklahoma City (Mirvetuximab

Withdrawn
  • Endometrial Cancer
  • +3 more
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Jun 25, 2019

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in Canada, Hong

Completed
Has Results
  • Endometrial Adenocarcinoma
  • +11 more
  • Bevacizumab
  • +4 more
  • Berkeley, California
  • +40 more
Feb 15, 2018